TRACON Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
TCON TRACON Pharmaceuticals Inc
HLIT Harmonic Inc
MTBCP MTBC Inc
MTBC MTBC Inc
GSBD Goldman Sachs BDC Inc
YUMA Yuma Energy Inc
BAC Bank of America Corp
$GSPIN S&P INTERNET&CAT
LJPC La Jolla Pharmaceutical Co
NBR Nabors Industries Ltd
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap ValueCompany profile

TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company's research focuses on antibodies that bind to the endoglin receptor, which is essential to angiogenesis (the process of new blood vessel formation) and a contributor to fibrosis (tissue scarring). The Company's lead product candidate, TRC105, is an endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor (VEGF) pathway. TRC205 is being developed for the treatment of fibrotic disease. The Company is also developing TRC102, a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma.

Closing Price
$3.66
Day's Change
0.39 (11.93%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.67
Day's Low
3.18
Volume
(Heavy Day)
Volume:
36,570

10-day average volume:
27,434
36,570
  • Prev Close
    3.27
  • Today's Open
    3.18
  • Day's Range
    3.18-3.67
  • Avg Vol (10-day)
    27.4K
  • Last (time)
    4:00p ET 11/20/19
  • Last (size)
    1
  • 52-Wk Range
    2.78 - 17.30
    LowHigh
  • (04/02/19 - 10/23/19)
    31.61%
  • 116.2%
  • Market Cap
    11.5M
  • Shares Outstanding
    3.1M
  • -8.86
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.2
  • 595.71
  • (% of float 10/31/19)
    33.92

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.